What are essential competencies for cancer care teams?
Identifying cancer care team competencies to improve health care delivery
Challenge
Delivering cancer care can be challenging. It involves integrating a number of issues, including extreme specialization, geographic dispersion, and the multitude of teams. Cancer care team members are often minimally trained in teamwork, particularly in multiteam care systems competencies.
So, how can care be effectively coordinated across the cancer care continuum?
For the National Cancer Institute (NCI), Westat used the Delphi technique to determine key knowledge, skills, attitudes, and other characteristics the cancer workforce need to team effectively and efficiently within and across care settings.
Solution
Westat administered 3 rounds of an online Delphi survey to cancer care stakeholders. The Delphi technique is a structured process, where, over the course of discussions and data collection, a group arrives at a consensus.
Stakeholders included oncologists, primary care doctors, nurses, palliative care professionals, team researchers, patient groups, and caregivers.
Working with NCI, Westat prepared a manuscript of the study methods and results to distribute to potential cancer care team training providers.
Results
The data gathered will inform future team training curricula and, ultimately, help improve health care delivery.
Focus Areas
Health Communications Health Services Research and Health Policy Public HealthCapabilities
Partnership EngagementSenior Expert Contact
Sophia Tsakraklides
Principal Research Associate
-
Expert Interview
Safeguarding Data Privacy: Innovations at WestatOctober 2025
Protecting the privacy of people who respond to surveys and censuses is a critical responsibility in federal data collection. During the 2010 Decennial Census, the…
-
Expert Interview
Novel Strategies Transform Clinical Trials Into Future OpportunitiesOctober 2025
For the rigorous evaluation of novel medicines, clinical trials are essential to ensure safety and efficacy. However, clinical trials are experiencing turbulent times due to…
-
Expert Interview
Real-World Insights: Nirsevimab’s Protection Against RSV in InfantsSeptember 2025
Each year in the U.S., respiratory syncytial virus, commonly known as RSV, leads to approximately 58,000 to 80,000 hospitalizations among children under age 5. The…